Bob Valamehr – Biography

Last update: April 16, 2026

Executive profile

Bob was Associate, Research and Development for Amgen. Bob Valamehr joined Fate Therapeutics in 2024. Bob served as Vice President, Cancer Immunotherapy at Fate Therapeutics.

Bob Valamehr is currently

Chief Executive Officer and President at Fate Therapeutics - View - Fate Therapeutics org chart



Create your alert
to follow the career of Bob Valamehr.

Education

Bob Valamehr has a MBA Global Business from Pepperdine University, The George L. Graziadio School of Business and Management and a PhD Molecular & Medical Pharmacology; Embryonic Stem Cell Research from University of California, Los Angeles.

They have also studied at Pepperdine University, The George L. Graziadio School of Business and Management :

Find more alumni from Pepperdine University, The George L. Graziadio School of Business and Management


They have also studied at University of California, Los Angeles :

Find more alumni from University of California, Los Angeles

The colleagues of Bob Valamehr

Company Colleagues
Industry Colleagues
  • In the Biotechnology industry, Bob Valamehr has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Bob Valamehr.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard, call Fate Therapeutics at +1 858... and ask for Bob Valamehr.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.